A new study by a team of researchers at the University of Toronto's Emerging and Pandemic Infections Consortium (EPIC) has uncovered biological reasons underlying sex differences in COVID-19 outcomes, offering a promising new strategy to prevent illness. The pre-clinical research, published in the journal iScience , has yet to be replicated in humans, but points to the ACE2 protein as a key contributor to differences in COVID-19 outcomes between males and females. During the early days of the pandemic, clinicians noticed that males were more likely than females to be hospitalized or admitted to the ICU or to die from COVID-19 despite having similar infection rates.

https://www.miragenews.com/research-men-more-prone-to-severe-covid-19-1096559/

#miragenews